TCL Archive Cancer Telethon Attracts Small Audience, Generates Expectations-And Questions. September 12, 2008
TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive DRG Executives Names By DeVita as Director Of DEA; Other Sections Reportedly Made, Not Yet Approved July 31, 1981
TCL Archive Administration Pledges To Fund Increase For NIH Regardless Of Tobacco Legislation February 6, 1998
TCL Archive New Biologic Modalities Show Promise In Treatment Of Lymphomas, Research Finds June 28, 2002